Negative clinical trials in sarcoidosis: Failed therapies or flawed study design?

European Respiratory Journal

Volumn 44, Issue 5, 2014, Pages 1123-1126

  Moller, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; GOLIMUMAB; INFLIXIMAB; INTERLEUKIN 12; INTERLEUKIN 23; PLACEBO; PREDNISONE; TUMOR NECROSIS FACTOR; USTEKINUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ACUTE DISEASE; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; EDITORIAL; FORCED VITAL CAPACITY; GRANULOMATOUS INFLAMMATION; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; SARCOIDOSIS; SKIN DISEASE; SYMPTOM; TREATMENT RESPONSE; FEMALE; MALE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; MALE; SARCOIDOSIS;

EID: 84937630731     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00156314     Document Type: Editorial

References (20)

1. Judson MA, Baughman RP, Costabel U, et al. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur Respir J 2014; 44: 1296-1307.
2. Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med 2010; 31: 390-403.
3. Chen ES, Moller DR. Sarcoidosis-scientific progress and clinical challenges. Nat Rev Rheumatol 2011; 7: 457-467.
4. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174: 795-802.
5. Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial. Eur Respir J 2008; 31: 1189-1196.
6. Stagaki E, Mountford WK, Lackland DT, et al. The treatment of lupus pernio: Results of 116 treatment courses in 54 patients. Chest 2009; 135: 468-476.
7. Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999; 78: 65-111.
8. Vorselaars AD, Wuyts WA, Vorselaars VM, et al. Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest 2013; 144: 805-812.
9. Judson MA, Baughman RP, Costabel U, et al. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: A retrospective analysis from a randomized clinical trial. Respir Med 2014; 108: 189-194.
10. Panselinas E, Judson MA. Acute pulmonary exacerbations of sarcoidosis. Chest 2012; 142: 827-836.
11. Munro CS, Mitchell DN. The Kveim response: still useful, still a puzzle. Thorax 1987; 42: 321-331.
12. Vorselaars AD, Verwoerd A, van Moorsel CH, et al. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur Respir J 2014; 43: 602-609.
13. Panselinas E, Rodgers JK, Judson MA. Clinical outcomes in sarcoidosis after cessation of infliximab treatment. Respirology 2009; 14: 522-528.
14. Gottlieb JE, Israel HL, Steiner RM, et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111: 623-631.
15. McKinzie BP, Bullington WM, Mazur JE, et al. Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci 2010; 339: 1-4.
16. Park MK, Fontana Jr, Babaali H, et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2009; 26: 121-131.
17. Baughman RP, Drent M, Culver DA, et al. Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29: 90-98.
18. Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet 2014; 383: 1155-1167.
19. Baughman RP, Shipley R, Desai S, et al. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest 2009; 136: 526-535.
20. Baughman RP, Nunes H, Sweiss NJ, et al. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J 2013; 41: 1424-1438.